Jazz Pharma(JAZZ.US)

Event Tracking

Feb25

Jazz Pharma released FY2025 annual earnings on February 24 After-Market (EST), actual revenue USD 4.268 B (forecast USD 4.239 B), actual EPS USD -5.8403 (forecast USD -6.1738)

00:00

Jazz Pharma released FY2025 Q4 earnings on February 24 After-Market EST, actual revenue USD 1.198 B (forecast USD 1.165 B), actual EPS USD 3.2071 (forecast USD 2.8929)

00:00

Feb17

Jazz Pharma to release FY2025 Q4 earnings on February 24 After-Market EST, forecast revenue USD 1.165 B, EPS USD 2.8929

00:42

Jan12

Jazz Pharmaceuticals Acquires Chimerix and Incorporates into Its Strategy

14:04

Analysts Upgrade Jazz Pharmaceuticals Ratings and Target Price

12:07

Jan6

Needham Maintains Jazz Pharmaceuticals Buy Rating With $210 Price Target

19:17